Relationship between gene polymorphisms of two cytokine genes (TNF-α and IL-6) and occurring of lung cancers in the ethnic group Han of China

Molecular Biology Reports

Volumn 40, Issue 2, 2013, Pages 1541-1546

  Liang, Jing ^a   Liu, Xiaolin ^a   Bi, Zhenqiang ^b   Yin, Beibei ^a   Xiao, Junjuan ^a   Liu, Hairong ^a   Li, Yan ^a  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

Genetic polymorphisms; IL 6; Lung cancer; SNPs; TNF

Indexed keywords

INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER GRADING; CANCER SUSCEPTIBILITY; CHINESE; CONTROLLED STUDY; ETHNICITY; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; IL 6 GENE; LUNG CANCER; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; TNF ALPHA GENE;

BASE SEQUENCE; CASE-CONTROL STUDIES; CHINA; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; LUNG NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84878363278     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-012-2199-2     Document Type: Article

References (38)

1. Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP (2008) Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther 117:244-279
2. Wu Y, Zhou BP (2010) TNF-alpha/NF-kappaB/Snail pathway in cancer cell migration and invasion. Br J Cancer 102:639-644
3. Sethi G, Sung B, Kunnumakkara AB, Aggarwal BB (2009) Targeting TNF for treatment of cancer and autoimmunity. Adv Exp Med Biol 647:37-51
4. Young RJ, Tin AW, Brown NJ, Jitlal M, Lee SM, Woll PJ (2012) Analysis of circulating angiogenic biomarkers from patients in two phase III trials in lung cancer of chemotherapy alone or chemotherapy and thalidomide. Br J Cancer 106:1153-1159
5. Sansone P, Bromberg J (2012) Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol 30:1005-1014
6. Yannelli JR, Tucker JA, Hidalgo G, Perkins S, Kryscio R, Hirschowitz EA (2009) Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer. Oncol Rep 22:1459-1471
7. Jatoi A, Qi Y, Kendall G et al (2010) The cancer anorexia/weight loss syndrome: exploring associations with single nucleotide polymorphisms (SNPs) of inflammatory cytokines in patients with non-small cell lung cancer. Support Care Cancer 18:1299-1304
8. Miki Y, Suzuki T, Abe K et al (2010) Intratumoral localization of aromatase and interaction between stromal and parenchymal cells in the non-small cell lung carcinoma microenvironment. Cancer Res 70:6659-6669
9. Crawford A, Fassett RG, Geraghty DP et al (2012) Relationships between single nucleotide polymorphisms of antioxidant enzymes and disease. Gene 501:89-103
10. Sato-Otsubo A, Sanada M, Ogawa S (2012) Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how? Semin Oncol 39:13-25
11. Christianson MS, Yates M (2012) Scavenger receptor class B type 1 gene polymorphisms and female fertility. Curr Opin Endocrinol Diabetes Obes 19:115-120
12. Fehringer G, Liu G, Briollais L et al (2012) Comparison of pathway analysis approaches using lung cancer GWAS data sets. PLoS One 7:e31816
13. de Andrade M, Li Y, Marks RS et al (2012) Genetic variants associated with the risk of chronic obstructive pulmonary disease with and without lung cancer. Cancer Prev Res (Phila) 5:365-373
14. Barbisan G, Pérez LO, Contreras A et al (2012) TNF-α and IL-10 promoter polymorphisms, HPV infection, and cervical cancer risk. Tumour Biol 33:1549-1556
15. Yang Y, Luo C, Feng R et al (2011) The TNF-α, IL-1B and IL-10 polymorphisms and risk for hepatocellular carcinoma: a meta-analysis. J Cancer Res Clin Oncol 137:947-952
16. Wang B, Wang J, Zheng Y et al (2010) A study of TNF-alpha -238 and -308 polymorphisms with different outcomes of persistent hepatitis B virus infection in China. Pathology 42:674-680
17. Yin YW, Sun QQ, Hu AM et al (2012) Associations between interleukin-6 gene -174 C/G and -572 C/G polymorphisms and the risk of gastric cancer: A meta-analysis. J Surg Oncol (in press)
18. Bouma G, Crusius JBA, Oudkerk Pool M et al (1996) Secretion of tumour necrosis factor and lymphotoxin in relation to polymorphisms in TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 43:456-463
19. Hajeer AH, Hutchinson IV (2001) Influence of TNFα gene polymorphisms on TNFα production and disease. Hum Immunol 62:1191-1199
20. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW (1993) An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8 and DR3 alleles. J Exp Med 177:557-560
21. D'Alfonso S, Richiardi PM (1994) A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39:150-154
22. Auguet T, Vidal F, López-Dupla M et al (2008) A study on the TNF-α system in Caucasian Spanish patients with alcoholic liver disease. Drug Alcohol Depend 92:91-99
23. Khoo SH, Pepper L, Snowden N et al (1997) Tumor necrosis factor c2 micro satellite allele is associated with the rate of HIV progression. AIDS 11:423-428
24. Knuchel MC, Spira TJ, Neumman AU et al (1998) Analysis of a biallelic polymorphism in the tumor necrosis factor alpha promoter and HIV type 1 disease progression. AIDS Res Hum Retrovir 14:305-309
25. Konenkov VI, Smolnikova MV (2002) Polymorphism of promotor sites of Interleukins-4 and -10 and tumour necrosis factor-α genes in HIV-infected patients. Bull Exp Biol Med 4:389-391
26. Wang C, Song W, Lovashevsky E et al (2004) Cytokine and chemokine gene polymorphisms among ethnically diverse North Americans with HIV-1 infection. J Acquir Immune Defic Syndr 35:446-454
27. Erikstrup C, Kallestrup P, Zinyama-Gutsire RB et al (2007) Reduced mortality and CD4 cell loss among carriers of the interleukin-10 -1082G allele in a Zimbabwean cohort of HIV-1-infected adults. AIDS 21:2283-2291
28. Scaccabarozzi A, Arosio P, Weiss G et al (2000) Relationship between TNF a and iron metabolism in differentiating human monocytic TNP-1 cells. Br J Haematol 110:978-984
29. Hirayama M, Kohgo Y, Kondo H et al (1993) Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposit of iron. Hepatology 18:874-880
30. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC (1997) Secretion of ferritin by rat hepatoma cells and its regulation by inflammatory cytokines and iron. Blood 90:4979-4986
31. Collins FS, Patrinos A, Jordan E, Chakravarti A, Gesteland R, Walters L (1998) New goals for the U.S. human genome project: 1998-2003. Science 282:682-689
32. Wang DG, Fan JB, Siao CJ et al (1998) Large-scale identification, mapping, and genotyping of single-nucleotide polymorphisms in the human genome. Science 280:1077-1082
33. Roses AD (2000) Pharmacogenetics and the practice of medicine. Nature 405:857-865
34. Kruglyak L, Nickerson DA (2001) Variation is the spice of life. Nat Genet 27:234-236
35. Przeworski M, Hudson RR, Di Rienzo A (2000) Adjusting the focus on human variation. Trends Genet 16:296-302
36. Li Y, Liang J, Liu XL, Liu HR, Yin BB, Xiao JJ, Bi ZQ (2012) Correlation of polymorphisms of the vascular endothelial growth factor gene and the risk of lung cancer in an ethnic Han group of North China. Exp Ther Med 3:673-676
37. Liang J, Li Y, Liu X, Xu X, Zhao Y (2011) Relationship between cytokine levels and clinical classification of gastric cancer. Asian Pac J Cancer Prev 12:1803-1806
38. Zhou P, Lv GQ, Wang JZ et al (2011) The TNF-alpha -238 polymorphism and cancer risk: a meta-analysis. PLoS One 6:e22092